SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

Genomics analysis using next-generation sequencing (NGS) technology is fundamental to successful high-throughput testing of a broad range of samples. NGS is particularly impactful for rare disease ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

A low DNA binding consumables range minimizes interactions between nucleic acids and plastic surfaces, supporting more ...

Genient, a Noida-based genomics and molecular diagnostics company founded in 2017, is strengthening India's precision ...

Introduction While pathogen genomics using next-generation sequencing (NGS) has been recommended by the WHO as an essential ...

Please provide your email address to receive an email when new articles are posted on . Real-world data show that only about 30% to 40% of patients with the most common cancers receive NGS testing.

New validated automated workflows enable higher-throughput, more reproducible NGS library preparation using on-deck fragmentation, ligation, and auto-normalization.